Benredjem, B., Benredjem, B., Pineyro, G., & Pineyro, G. (2023). A type II cannabis extract and a 1: 1 blend of Δ(9)-tetrahydrocannabinol and cannabidiol display distinct antinociceptive profiles and engage different endocannabinoid targets when administered into the subarachnoid space. Frontiers Media S.A.
Chicago Style (17th ed.) CitationBenredjem, Besma, Besma Benredjem, Graciela Pineyro, and Graciela Pineyro. A Type II Cannabis Extract and a 1: 1 Blend of Δ(9)-tetrahydrocannabinol and Cannabidiol Display Distinct Antinociceptive Profiles and Engage Different Endocannabinoid Targets When Administered into the Subarachnoid Space. Frontiers Media S.A, 2023.
MLA (9th ed.) CitationBenredjem, Besma, et al. A Type II Cannabis Extract and a 1: 1 Blend of Δ(9)-tetrahydrocannabinol and Cannabidiol Display Distinct Antinociceptive Profiles and Engage Different Endocannabinoid Targets When Administered into the Subarachnoid Space. Frontiers Media S.A, 2023.